OMCL logo

OMCL
Omnicell, Inc.

771
Mkt Cap
$1.96B
Volume
34,391.00
52W High
$55.00
52W Low
$26.85
PE Ratio
97.85
OMCL Fundamentals
Price
$42.74
Prev Close
$43.17
Open
$43.87
50D MA
$37.77
Beta
0.85
Avg. Volume
566,271.57
EPS (Annual)
$0.0443
P/B
1.56
Rev/Employee
$330,962.29
$2,053.51
Loading...
Loading...
News
all
press releases
Can Platform Expansion Support Hims & Hers Stock Before Q1 Earnings?
HIMS first-quarter 2026 results are likely to benefit from Labs and branded weight loss medications even as higher costs and GLP-1 scrutiny linger.
Zacks·6d ago
News Placeholder
More News
News Placeholder
Here's Why Omnicell (OMCL) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks·7d ago
News Placeholder
DaVita Stock Up Following Q1 Earnings & Revenue Beat, Margins Expand
DVA's first-quarter 2026 results benefit from expanding margins and steady dialysis demand across its broad clinic network.
Zacks·8d ago
News Placeholder
Omnicell (OMCL) is a Great Momentum Stock: Should You Buy?
Does Omnicell (OMCL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks·9d ago
News Placeholder
Zacks Industry Outlook Highlights Veeva Systems, Doximity and Omnicell
Veeva Systems, Doximity and Omnicell ride rising AI-driven healthcare demand as medical info systems expand despite cybersecurity and regulatory risks.
Zacks·9d ago
News Placeholder
Omnicell to Present at the BofA Securities 2026 Healthcare Conference
Omnicell, Inc. (Nasdaq:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, announced that it will present at the BofA Securities 2026 Healthcare Conference on Tuesday, May 12, 2026, at 8:40 a.m. PDT. Live and archived webcasts of the presentation...
Business Wire·10d ago
News Placeholder
3 Medical Info Systems Stocks Riding the GenAI Wave in a Tough Market
Doximity, Veeva and Omnicell ride surging GenAI adoption in healthcare, tapping digital demand despite market pressure and rising cybersecurity risks.
Zacks·10d ago
News Placeholder
Surging Earnings Estimates Signal Upside for Omnicell (OMCL) Stock
Omnicell (OMCL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Zacks·10d ago
News Placeholder
Wall Street Analysts See a 41.19% Upside in Omnicell (OMCL): Can the Stock Really Move This High?
The mean of analysts' price targets for Omnicell (OMCL) points to a 41.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks·10d ago
News Placeholder
Omnicell (NASDAQ:OMCL) Raised to Buy at Wall Street Zen
Wall Street Zen raised shares of Omnicell from a "hold" rating to a "buy" rating in a research report on Saturday...
MarketBeat·12d ago
<
1
2
...
>

Latest OMCL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.